Stock

Hyundai India drops 5% on debut after record $3.3 billion IPO

By Nandan Mandayam

(Reuters) -Hyundai Motor India’s shares dropped 5% in their market debut on Tuesday, after a tepid response from retail investors to the country’s largest ever initial public offering over its pricing.

The stock listed at 1,934 rupees on the National Stock Exchange, compared to its offer price of 1,960 rupees, and was last trading at 1,860 rupees at 0502 GMT, giving the company a valuation of 1.51 trillion rupees ($17.96 billion).

Hyundai, India’s No. 2 carmaker with a 15% market share, was targeting a valuation of $19 billion through the IPO.

Its record $3.3 billion IPO was oversubscribed more than two-fold last week, led largely by institutional investors, but pricing concerns deterred participation by retail investors who worried they would not be able to make gains on the listing.

“Hyundai’s issue has been stiffly priced and that seems to be weighing down on its listing as well. Besides, the volumes seen so far are driven only by institutional investors, and is rather poor for an IPO of Hyundai’s size,” said Arun Kejriwal, founder of Kejriwal Research.

Tuesday’s listing in Mumbai is Hyundai Motor (OTC:HYMTF)’s first such debut outside its home market of South Korea and comes at a time when India’s equity markets have risen sharply.

The two-biggest IPOs prior to Hyundai India – Life Insurance Corporation and Paytm parent One97 communications – both listed at steep discounts of 8% and 9%, respectively.

Overall, only two of India’s 10 largest IPOs have outperformed the S&P CNX 500 index since listing, according to a report published by Capitalmind last week.

While Hyundai’s market valuation is much smaller than Indian market leader Maruti Suzuki’s $45 billion, analysts have expressed concerns over the narrower gap when valued by their price-to-earnings (P/E) ratios.

The issue had valued Hyundai at 26 times its fiscal 2024 earnings, not far off the 29 times multiple for market leader Maruti.

Some major brokerages, however, see long term value in the stock.

Nomura started coverage of Hyundai with a “buy” rating and price target of 2,472 rupees. The brokerage said it liked Hyundai’s high concentration of SUVs in the portfolio, which formed 67% of its sales in the April-June 2024 quarter.

Similarly, Macquarie analysts began coverage with an “outperform” rating and price target of 2,235 rupees, arguing that Hyundai’s SUV-centric portfolio commanded a P/E premium.

Shares of rivals Maruti and Tata Motors (NYSE:TTM) were down 2%. The Nifty Auto index was down 1.7%.

Hyundai’s listing comes as car sales slow down in India after two years of record highs, with customers delaying purchases on worries about recalcitrant inflation.

($1 = 84.0720 Indian rupees)

This post appeared first on investing.com

You May Also Like

Editor's Pick

Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

Latest News

A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

Economy

A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

Investing

Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 balanceandcharge.com

Exit mobile version